DK1190056T3 - Human cytokin receptor - Google Patents

Human cytokin receptor

Info

Publication number
DK1190056T3
DK1190056T3 DK00947028T DK00947028T DK1190056T3 DK 1190056 T3 DK1190056 T3 DK 1190056T3 DK 00947028 T DK00947028 T DK 00947028T DK 00947028 T DK00947028 T DK 00947028T DK 1190056 T3 DK1190056 T3 DK 1190056T3
Authority
DK
Denmark
Prior art keywords
cytokine receptor
human cytokine
fab
seq
amino acid
Prior art date
Application number
DK00947028T
Other languages
Danish (da)
English (en)
Inventor
Scott R Presnell
Steven K Burkhead
Sarah L Pownder
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of DK1190056T3 publication Critical patent/DK1190056T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK00947028T 1999-07-07 2000-06-30 Human cytokin receptor DK1190056T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34885499A 1999-07-07 1999-07-07
PCT/US2000/018383 WO2001004304A1 (fr) 1999-07-07 2000-06-30 Recepteur de cytokine humaine

Publications (1)

Publication Number Publication Date
DK1190056T3 true DK1190056T3 (da) 2007-07-30

Family

ID=23369838

Family Applications (2)

Application Number Title Priority Date Filing Date
DK00947028T DK1190056T3 (da) 1999-07-07 2000-06-30 Human cytokin receptor
DK07006343.3T DK1860188T3 (da) 1999-07-07 2000-06-30 Human cytokin-receptor

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK07006343.3T DK1860188T3 (da) 1999-07-07 2000-06-30 Human cytokin-receptor

Country Status (10)

Country Link
EP (3) EP2241623A3 (fr)
JP (1) JP4737903B2 (fr)
AT (2) ATE508193T1 (fr)
AU (1) AU6069800A (fr)
CA (1) CA2378519C (fr)
DE (2) DE60045931D1 (fr)
DK (2) DK1190056T3 (fr)
ES (2) ES2286029T3 (fr)
IL (1) IL147336A0 (fr)
WO (1) WO2001004304A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7771719B1 (en) 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
AU740405B2 (en) 1998-05-15 2001-11-01 Genentech Inc. IL-17 homologous polypeptides and therapeutic uses thereof
DK1897945T3 (da) * 1999-12-23 2012-05-07 Genentech Inc IL-17 homologe polypeptider og terapeutiske anvendelser deraf.
JP2003527104A (ja) * 1999-12-23 2003-09-16 ジェネンテック・インコーポレーテッド Ｉｌ−１７相同的ポリペプチドとその治療上の用途
ES2380812T3 (es) * 1999-12-23 2012-05-18 Genentech, Inc. Polipéptidos homólogos a IL-17 y usos terapéuticos de los mismos
US20040043397A1 (en) 2000-01-11 2004-03-04 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
JP2016047051A (ja) * 1999-12-23 2016-04-07 ジェネンテック， インコーポレイテッド Ｉｌ−１７相同的ポリペプチドとその治療上の用途
US7718397B2 (en) 2000-03-21 2010-05-18 Genentech, Inc. Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
US20030096969A1 (en) 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
DE60123998T2 (de) 2000-08-08 2007-09-06 Zymogenetics, Inc., Seattle Lösliche zcyctor 11 cytokinrezeptoren
WO2002038764A2 (fr) * 2000-11-10 2002-05-16 The Regents Of The University Of California Proteine de type recepteur il-17, utilisation de celle-ci et modulation de l'activite catabolique des cytokines il-17 sur l'os et le cartilage
JP2007525438A (ja) 2003-03-24 2007-09-06 ザイモジェネティクス， インコーポレイテッド 抗ｉｌ−２２ｒａ抗体および結合パートナー、ならびに炎症における使用法
EP2784084B2 (fr) 2003-07-08 2023-10-04 Novartis Pharma AG Polypeptides hétérologues IL-17 A/F et utilisations thérapeutiques associées
US7910540B2 (en) 2004-06-10 2011-03-22 Zymogenetics, Inc. Soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners and methods of using in inflammation
CA2583578C (fr) * 2004-10-21 2014-04-01 Ge Healthcare Bio-Sciences Ab Ligand de chromatographie
AU2005299809B2 (en) 2004-10-22 2010-12-02 Zymogenetics, Inc. Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
JP2009510093A (ja) * 2005-09-28 2009-03-12 ザイモジェネティクス， インコーポレイテッド Ｉｌ−１７ａおよびｉｌ−１７ｆアンタゴニストならびにその使用方法
US20070249533A1 (en) 2005-09-28 2007-10-25 Levin Steven D Il-17a and il-17f antagonists and methods of using the same
AU2006328899A1 (en) * 2005-12-22 2007-06-28 Merck Serono Sa Soluble IL-17RC variant and uses thereof
US20070197441A1 (en) * 2006-02-10 2007-08-23 Rixon Mark W Truncated il-17ra soluble receptor and methods of using in inflammation
WO2008039553A1 (fr) 2006-02-10 2008-04-03 Zymogenetics, Inc. Il-17rcx4 soluble et procédés d'utilisation dans l'inflammation
US7790676B2 (en) 2007-03-28 2010-09-07 Zymogenetics, Inc. Soluble IL-17RA/RC fusion proteins
RU2474588C2 (ru) 2008-05-05 2013-02-10 Новиммун Са Перекрестно-реактивные антитела анти-il-17a/il-17f и способы их применения
CN102458437B (zh) 2009-05-05 2015-06-10 诺维莫尼公司 抗il-17f抗体及其使用方法

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331647A (en) 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4615974A (en) 1981-08-25 1986-10-07 Celltech Limited Yeast expression vectors
US4769331A (en) 1981-09-16 1988-09-06 University Patents, Inc. Recombinant methods and materials
US4486533A (en) 1982-09-02 1984-12-04 St. Louis University Filamentous fungi functional replicating extrachromosomal element
US4599311A (en) 1982-08-13 1986-07-08 Kawasaki Glenn H Glycolytic promotersfor regulated protein expression: protease inhibitor
US4977092A (en) 1985-06-26 1990-12-11 Amgen Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells
US4603044A (en) 1983-01-06 1986-07-29 Technology Unlimited, Inc. Hepatocyte Directed Vesicle delivery system
US4661454A (en) 1983-02-28 1987-04-28 Collaborative Research, Inc. GAL1 yeast promoter linked to non galactokinase gene
US5139936A (en) 1983-02-28 1992-08-18 Collaborative Research, Inc. Use of the GAL1 yeast promoter
US4870008A (en) 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
DE3572982D1 (en) 1984-03-06 1989-10-19 Takeda Chemical Industries Ltd Chemically modified lymphokine and production thereof
US4931373A (en) 1984-05-25 1990-06-05 Zymogenetics, Inc. Stable DNA constructs for expression of α-1 antitrypsin
US4859587A (en) 1984-06-04 1989-08-22 Institut Merieux Recombinant herpes simplex viruses, vaccines and methods
US5288641A (en) 1984-06-04 1994-02-22 Arch Development Corporation Herpes Simplex virus as a vector
US4766073A (en) 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
DE3578435D1 (de) 1984-12-06 1990-08-02 Labofina Sa Promotoren fuer die expression von fremden genen in hefe, plasmide, die diese promotoren enthalten, sowie deren verwendung zur herstellung von polypeptiden.
DE229046T1 (de) 1985-03-30 1987-12-17 Marc Genf/Geneve Ballivet Verfahren zum erhalten von dns, rns, peptiden, polypeptiden oder proteinen durch dns-rekombinant-verfahren.
US4882279A (en) 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4935349A (en) 1986-01-17 1990-06-19 Zymogenetics, Inc. Expression of higher eucaryotic genes in aspergillus
GB8611832D0 (en) 1986-05-15 1986-06-25 Holland I B Polypeptide
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5063154A (en) 1987-06-24 1991-11-05 Whitehead Institute For Biomedical Research Pheromone - inducible yeast promoter
US5637677A (en) 1987-07-16 1997-06-10 The Trustees Of The University Of Pennsylvania Biologically active compounds and methods of constructing and using the same
US5037743A (en) 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5162228A (en) 1988-12-28 1992-11-10 Takeda Chemical Industries, Ltd. Gylceraldehyde-3-phosphate dehydrogenase gene and promoter
US5168053A (en) 1989-03-24 1992-12-01 Yale University Cleavage of targeted RNA by RNAase P
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5225337A (en) 1989-09-25 1993-07-06 Innovir Laboratories, Inc. Ribozyme compositions and methods for use
EP0438803B1 (fr) 1990-01-26 1997-03-12 Immunomedics, Inc. Vaccins contre le cancer et les maladies infectieuses
US5747334A (en) 1990-02-15 1998-05-05 The University Of North Carolina At Chapel Hill Random peptide library
US5328688A (en) 1990-09-10 1994-07-12 Arch Development Corporation Recombinant herpes simplex viruses vaccines and methods
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
US5208146A (en) 1990-11-05 1993-05-04 The Regents Of The University Of California Murine monoclonal anti-idiotype antibodies
US5252714A (en) 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
JP3202999B2 (ja) 1991-01-31 2001-08-27 協和醗酵工業株式会社 肝移行性リポソーム製剤
US5298418A (en) 1991-09-16 1994-03-29 Boyce Thompson Institute For Plant Research, Inc. Cell line isolated from larval midgut tissue of Trichoplusia ni
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US5783384A (en) 1992-01-13 1998-07-21 President And Fellows Of Harvard College Selection of binding-molecules
US5496698A (en) 1992-08-26 1996-03-05 Ribozyme Pharmaceuticals, Inc. Method of isolating ribozyme targets
US5525468A (en) 1992-05-14 1996-06-11 Ribozyme Pharmaceuticals, Inc. Assay for Ribozyme target site
CA2136764A1 (fr) 1992-05-29 1993-12-09 Ronald L. Marshall Reaction en chaine a la ligase a partir de sequences d'arn
US5382657A (en) 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
EP0742830B1 (fr) 1994-02-01 2001-07-18 THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services Proteines de fusion comprenant des parties anticorps et non anticorps
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5631359A (en) 1994-10-11 1997-05-20 Ribozyme Pharmaceuticals, Inc. Hairpin ribozymes
US5738846A (en) 1994-11-10 1998-04-14 Enzon, Inc. Interferon polymer conjugates and process for preparing the same
US5641655A (en) 1994-11-30 1997-06-24 Zymogenetics, Inc. Methods for producing thrombopoietin polypeptides using a mammalian tissue plasminogen activator secretory peptide
AU4961996A (en) 1994-12-14 1996-07-03 Innovir Laboratories, Inc. Ribozyme-mediated inactivation of leukemia-associated rna
US5683873A (en) 1995-01-13 1997-11-04 Innovir Laboratories, Inc. EGS-mediated inactivation of target RNA
US5965389A (en) 1995-11-09 1999-10-12 Zymogenetics, Inc. Production of GAD65 in methylotrophic yeast
US5716808A (en) 1995-11-09 1998-02-10 Zymogenetics, Inc. Genetic engineering of pichia methanolica
US5723125A (en) 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US5877162A (en) 1996-03-14 1999-03-02 Innovir Laboratories, Inc. Short external guide sequences
JP2002515746A (ja) 1996-07-17 2002-05-28 ザイモジェネティクス，インコーポレイティド ピヒア・メタノリカの形質転換
JP2002514049A (ja) 1996-07-17 2002-05-14 ザイモジェネティクス，インコーポレイティド ピヒア・メタノリカの栄養要求性突然変異体の製造
US5736383A (en) 1996-08-26 1998-04-07 Zymogenetics, Inc. Preparation of Pichia methanolica auxotrophic mutants
US5945511A (en) * 1997-02-20 1999-08-31 Zymogenetics, Inc. Class II cytokine receptor
WO1998049307A1 (fr) * 1997-05-01 1998-11-05 Zymogenetics, Inc. Recepteurs de mammiferes analogues de la cytokine
US5965704A (en) * 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11

Also Published As

Publication number Publication date
EP1860188B1 (fr) 2011-05-04
EP1190056B1 (fr) 2007-04-25
JP4737903B2 (ja) 2011-08-03
ATE360692T1 (de) 2007-05-15
JP2003504058A (ja) 2003-02-04
ES2286029T3 (es) 2007-12-01
EP1860188A3 (fr) 2008-08-27
WO2001004304A1 (fr) 2001-01-18
AU6069800A (en) 2001-01-30
ES2364086T3 (es) 2011-08-24
DE60045931D1 (de) 2011-06-16
HK1115607A1 (en) 2008-12-05
DE60034564D1 (de) 2007-06-06
EP1190056A1 (fr) 2002-03-27
CA2378519C (fr) 2011-01-25
ATE508193T1 (de) 2011-05-15
EP2241623A2 (fr) 2010-10-20
EP1860188A2 (fr) 2007-11-28
DE60034564T2 (de) 2007-12-27
IL147336A0 (en) 2002-08-14
DK1860188T3 (da) 2011-06-27
EP2241623A3 (fr) 2010-12-01
CA2378519A1 (fr) 2001-01-18

Similar Documents

Publication Publication Date Title
DK1190056T3 (da) Human cytokin receptor
BR9507594B1 (pt) anticorpo monoclonal com scfv humanizado, molécula de ácido nucleico recombinante e proteìna recombinante.
UA40611C2 (uk) Імунокон'югат, спосіб його виготовлення, фармацевтична композиція
NZ547157A (en) Interferon Alpha Antibodies and their uses
BG111004A (bg) Антитела, които се свързват с човешки интерлевкин-18, и методи за получаване и използване
FR08C0006I2 (fr) Anticorps monoclonaux humains contre le recepteur du facteur de croissance epidermique
DE69429095D1 (de) Humanisierte antikoerper
GB2286399A (en) Recombinant humanized anti-cytomegalovirus antibodies
DK1576112T3 (da) Cytokin-receptor zcytor17-multimerer
NO2007014I1 (no) Bevacizumab (rekombinant humanisert monoklonalt antistoff)
PT1141274E (pt) Receptor soluvel br43x2 e metodos para sua utilizacao
NO20025354L (no) Pattedyr-reseptorproteiner; beslektede reagenser og fremgangsmåter
WO2001090151A3 (fr) Proteines receptrices humaines, reactifs et methodes associes
WO2003048194A3 (fr) Peptide ou proteine contenant une boucle c'-d de la famille de recepteurs cd28
GR3025630T3 (en) Monoclonal antibody against human IgE
ATE375802T1 (de) Ccr5 antikörper pa14
WO1999046379A3 (fr) Proteines receptrices humaines; reactifs et procedes associes
ATE133708T1 (de) Immunogenisches peptid von echinococcus granulosis, dafür kodierende dns sowie diagnostische und therapeutische verwendungen
BG102513A (en) Method for the diagnostics and the treatment of flat cellular cancer
FI925321A0 (fi) Immunodiagnostiskt ledinflammationstest
EP1094080A3 (fr) Anticorps contre la DNse-gamma, sa production et utilisation
BR9702101A (pt) Hibridoma e anticorpo monoclonal
WO1999019480A3 (fr) Proteines receptrices humaines et reactifs et methodes associes
CA2107329A1 (fr) Anticorps recombinants anti-virus de l'immunodeficience humaine
ES2151646T3 (es) Procedimiento para la identificacion o dosificacion inmunologica de antigenos polipeptidicos.